Advances in Leukaemia therapy bring hope to patients worldwide

Westmead - LEUKAEMIA LABTwo Australian research teams have made exciting progress into leukaemia treatments, raising hope for patients around the world suffering from the blood disease.

In a study led by the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide’s Centre for Personalised Cancer Medicine, researchers are testing a promising new approach to killing off leukaemia cancer cells.

They have found that cancer cells decide whether to live or die after a short period of intense exposure to a targeted therapy, reducing current treatment time, leading to reduced side effects in patients.

Continue reading “Advances in Leukaemia therapy bring hope to patients worldwide”

Unprecedented success in trialling new adult leukaemia therapy

A new, potentially life-saving drug has raised new hope for patients in advanced stages of chronic lymphocytic leukaemia – one of the most common types of adult leukaemia in Australia.

In many cases this cancer becomes resistant to traditional treatment methods such as chemotherapy. This is because of its high levels of a “pro-survival” protein called BCL-2 that render cancer cells, according to Walter and Eliza Hall Institute haematologist Prof. Andrew Roberts “basically indestructible”.

Continue reading “Unprecedented success in trialling new adult leukaemia therapy”